Shin Nippon Biomedical Laboratories, Ltd.

Insider Reports History

Location
Kagoshima, Japan
Signature
Shin Nippon Biomedical Laboratories, Ltd., By: /s/ Shinji Nitanda, Director
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Shin Nippon Biomedical Laboratories, Ltd.:

Company Role Class Num Shares Value Price $ Report Date Ownership
Satsuma Pharmaceuticals, Inc. 10%+ Owner Common Stock 8,423,732 $7,665,596 $0.9100 08 Jun 2023 Indirect
Satsuma Pharmaceuticals, Inc. 10%+ Owner Common Stock 2,560,780 $2,330,310 $0.9100 06 Jun 2023 Direct

Insider Reports Filed by Shin Nippon Biomedical Laboratories, Ltd.

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000089924323014866-shin-nippon-biomedical-laboratories-ltd-2023-06-06 Satsuma Pharmaceuticals, Inc. 06 Jun 2023 2 +$27,734,355 4 10%+ Owner 08 Jun 2023, 16:24